J&J Consumer Business Picks Up, But Analysts See Long Road
This article was originally published in The Rose Sheet
Executive Summary
J&J’s consumer business inched up 1% operationally in Q3, including about 6% growth at constant currency in OTC/nutritionals. However, costs associated with the remediation of McNeil OTC facilities are expected to weigh on J&J through most of 2013.